Status:
UNKNOWN
Aminoglycosides and Duct
Lead Sponsor:
Carmel Medical Center
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
30-3 years
Brief Summary
The aim of the study is to assess the effect of aminoglycoside treatment on ductal closure in preterms
Eligibility Criteria
Inclusion
- infants born at or above 32 weeks of gestation
- \-
Exclusion
- infants who are unlikely to survive or have congenital heart defects
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04415554
Start Date
July 1 2021
End Date
December 1 2022
Last Update
February 9 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.